Henry Ward Wolff
Director/Board Member at CALITHERA BIOSCIENCES, INC.
Net worth: - $ as of 31/03/2024
Profile
Henry Ward Wolff is an Independent Director at Calithera Biosciences, Inc. He previously served as an Independent Director at MAP Pharmaceuticals LLC from 2008 to 2013, Sunesis Pharmaceuticals, Inc. from 2018 to 2021, and Portola Pharmaceuticals LLC from 2007 to 2020.
He was also an Executive Director at Russell Reynolds Associates, Inc. and Russell Reynolds Associates, Inc. (Germany) from 1985 to 1992.
Additionally, he held the position of Chief Financial Officer at Premenos Technology Corp.
from 1992 to 1998, Chief Financial Officer & Senior VP-Finance at Nuvelo, Inc. from 2006 to 2007, Chief Financial Officer & Senior VP-Finance at Abgenix, Inc. from 2004 to 2006, and Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2007 to 2017.
He was also the Chief Financial Officer & Senior Vice President at DoubleTwist, Inc. from 1998 to 2002 and Chief Financial Officer at QuantumShift, Inc. from 2002 to 2003.
Prior to his roles in the pharmaceutical industry, he worked as a Senior Audit Manager at Pricewaterhouse LLP.
Mr. Wolff obtained an undergraduate degree from the University of California, Berkeley and an MBA from Harvard Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
30/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Henry Ward Wolff active positions
Companies | Position | Start |
---|---|---|
CALITHERA BIOSCIENCES, INC. | Director/Board Member | 02/12/2014 |
Former positions of Henry Ward Wolff
Companies | Position | End |
---|---|---|
VIRACTA THERAPEUTICS, INC. | Director/Board Member | 24/02/2021 |
PORTOLA PHARMACEUTICALS, INC. | Director/Board Member | 01/01/2020 |
SANGAMO THERAPEUTICS, INC. | Director of Finance/CFO | 28/02/2017 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Director/Board Member | 01/03/2013 |
Nuvelo, Inc. | Director of Finance/CFO | 14/08/2007 |
Training of Henry Ward Wolff
University of California, Berkeley | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
CALITHERA BIOSCIENCES, INC. | Health Technology |
Private companies | 11 |
---|---|
Premenos Technology Corp.
Premenos Technology Corp. Specialty TelecommunicationsCommunications Premenos Technology Corp. develops electronic software commerce products and services. The company is based in Concord, CA. Premenos Technology was acquired by Harbinger Corp. on December 22, 1997 for $141.78 million. | Communications |
Nuvelo, Inc. | Health Technology |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
DoubleTwist, Inc.
DoubleTwist, Inc. Miscellaneous Commercial ServicesCommercial Services Doubletwist, Inc. provides genomic information and bioinformatics analysis technologies. The company is headquartered in Oakland, CA. | Commercial Services |
QuantumShift, Inc.
QuantumShift, Inc. Packaged SoftwareTechnology Services QuantumShift, Inc. develops software for the communications industry. The company is based in Novato, CA. The company was founded by Marc Weiser. | Technology Services |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Russell Reynolds Associates, Inc.
Russell Reynolds Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Russell Reynolds Associates, Inc. provides executive recruitment services. Its services include chief executive officer and board advisory services, culture assessment, executive search, global supply chain and leadership assessment. The company was founded in 1969 and is headquartered in New York, NY. | Commercial Services |
Pricewaterhouse LLP | Commercial Services |
Russell Reynolds Associates, Inc. (Germany)
Russell Reynolds Associates, Inc. (Germany) Miscellaneous Commercial ServicesCommercial Services Russell Reynolds Associates, Inc. engages in the provision of leadership advisory services. Its services include executive search, executive assessment, CEO succession, board evaluation, and transformation. The company was founded in 1985 and is headquartered in Frankfurt, Germany. | Commercial Services |
- Stock Market
- Insiders
- Henry Ward Wolff